Richard J Travers
3PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Aug 05, 2025
Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.Alec Stepanian, Richard J Travers, Angelina Tesfu
|Aug 15, 2024
Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors.Richard J Travers, Alec Stepanian, Iris Z Jaffe
|Nov 20, 2023
Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors.Yihua Wang, Richard J Travers, Alanna Farrell
Pageof 1
